Close Menu

NEW YORK (GenomeWeb) – Sequenom will move its laboratory operations in Grand Rapids, Michigan to its facility in Raleigh-Durham, North Carolina, the company said today.

Sequenom's cystic fibrosis carrier screen test, which previously ran out of its Grand Rapids lab, will now be performed in the North Carolina location. In addition, as part of the consolidation, the firm said it would discontinue its SensiGene Fetal RHD test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.